Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.

A new study found that oxalic acid, an organic compound found in humans and many plant-based foods, may also contribute to ...

Can your brain start consuming itself during a marathon? New research says yes- but don’t panic, your brain bounces back in ...

The following is a summary of “Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Marathon runners experience reversible changes in their brain myelin. These findings indicate that myelin (a substance that surrounds the neurons) exhibits behavior that was previously unknown, and ...

THE London Marathon is waiting a Chester woman who lives with multiple sclerosis as she raises money for a charity that support people with ...

Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

UK researchers have unveiled an innovative artificial intelligence (AI) tool, named MindGlide, designed to interpret and ...

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

The 27-year-old woman had to have major brain surgery to correct a rare condition called Chiari Malformation, which means ...